Product image of Midazolam Kalceks (Midazolam) supplied by GNH India

Midazolam Kalceks

Active Ingredient:
Midazolam
Origin:
EU

Midazolam Kalceks (Midazolam)

Midazolam, the active ingredient in Midazolam Kalceks, is a benzodiazepine presented as a sterile injectable for intramuscular, intravenous, and rectal use. It provides sedation, anxiolysis, and anticonvulsant effects for patients undergoing procedures, surgery, or experiencing acute seizures. It is used in controlled clinical settings to facilitate safe and comfortable procedures, and its rapid onset makes it suitable for emergency seizure management.

GNH India supplies Midazolam Kalceks as a licensed, GDP‑compliant supplier serving hospitals and clinics worldwide, ensuring consistent quality and regulatory compliance.

Manufacturer / TM Owner

Kalceks

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Midazolam is a benzodiazepine that provides sedation and seizure control across several clinical settings.
  • Procedural sedation: facilitates calm and pain‑free conditions during diagnostic or therapeutic procedures.
  • Pre‑operative anxiolysis: reduces anxiety and induces relaxation before surgery.
  • Induction of anesthesia: contributes to rapid loss of consciousness as part of an anesthetic regimen.
  • Acute seizure control: terminates ongoing seizures, especially in status epilepticus.
  • Sedation for intensive care: provides continuous sedation for mechanically ventilated patients.

How It Works

  • Midazolam acts as a positive allosteric modulator at the γ‑aminobutyric acid type A (GABA‑A) receptor complex. By binding to a distinct site on the receptor, it enhances the affinity of GABA for its chloride channel, increasing chloride influx and hyperpolarizing neuronal membranes. This potentiation of inhibitory neurotransmission reduces neuronal excitability, producing rapid sedative, anxiolytic, muscle‑relaxant, and anticonvulsant effects, and a short duration of action due to rapid redistribution.

Side Effects

Midazolam may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Drowsiness: feeling unusually sleepy or fatigued.
  • Dizziness: light‑headed sensation or loss of balance.
  • Impaired coordination: reduced motor control and clumsiness.
  • Respiratory depression: slowed breathing, especially at higher doses.
  • Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects

  • Severe respiratory depression: may require assisted ventilation.
  • Hypotension: significant drop in blood pressure.
  • Paradoxical reactions: agitation, aggression, or hallucinations.
  • Anaphylaxis: rare severe allergic response requiring immediate medical attention.

Precautions & Warnings

  • When using Midazolam, clinicians should observe several safety measures to minimize risks.
  • Assess respiratory function: monitor breathing rate and oxygen saturation before and during administration.
  • Monitor cardiovascular status: watch blood pressure and heart rate for hypotension.
  • Use caution in elderly: increased sensitivity may require lower doses.
  • Avoid abrupt discontinuation: taper to prevent withdrawal symptoms.
  • Contraindicated in severe respiratory depression: do not administer to patients with compromised ventilation.
  • Store at ambient temperature: keep in original packaging, protect from moisture and light.

Avoid Interactions

Midazolam can interact with other substances that affect the central nervous system or its metabolism.

Major Interactions (Avoid)

  • Opioids: additive respiratory depression.
  • Barbiturates: profound CNS depression.
  • Azole antifungals (e.g., ketoconazole): increased plasma levels.

Moderate Interactions (Monitor Closely)

  • Selective serotonin reuptake inhibitors (SSRIs): possible enhanced sedation.
  • Alcohol: additive CNS depression.

Frequently Asked Questions

Midazolam Kalceks is a benzodiazepine formulation used for procedural sedation, pre‑operative anxiety reduction, induction of anesthesia, and rapid control of acute seizures such as status epilepticus. It is administered by injection to provide fast‑acting calming and anticonvulsant effects in hospital settings.

Midazolam enhances the activity of the inhibitory neurotransmitter GABA at the GABA‑A receptor. By increasing chloride ion flow into neurons, it hyperpolarizes the cell membrane, reducing neuronal firing. This results in sedation, anxiolysis, muscle relaxation, and seizure suppression.

The dose of Midazolam Kalceks is individualized by the prescribing clinician based on the patient’s age, weight, clinical condition, route of administration, and desired depth of sedation. No fixed regimen is provided here; the prescriber sets the appropriate amount for each case.

Safety data for Midazolam during pregnancy and lactation are limited. Because it crosses the placenta and may be excreted in breast milk, it is generally avoided unless the potential benefit justifies the risk. Clinicians should evaluate each situation carefully and discuss alternatives when possible.

To request Midazolam Kalceks, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and required import documentation.

Compared with other benzodiazepines, Midazolam has a rapid onset and relatively short duration due to fast redistribution, making it suitable for brief procedures. Unlike longer‑acting agents such as diazepam, it allows quicker recovery. When compared with propofol, Midazolam provides less profound hypnosis but offers anxiolytic and anticonvulsant benefits.

Midazolam Kalceks should be stored at ambient temperature, preferably below 25 °C. Keep the vials in their original packaging, protect them from moisture, direct sunlight, and extreme temperature fluctuations to maintain potency and sterility.

Midazolam is supplied as a sterile injectable solution and can be given intramuscularly, intravenously, or rectally, depending on the clinical situation. The route is chosen by the healthcare professional to achieve the desired speed and depth of sedation or seizure control.

The most serious risks include severe respiratory depression, profound hypotension, paradoxical reactions such as agitation or aggression, and rare anaphylactic responses. Continuous monitoring of breathing, oxygen saturation, and cardiovascular status is essential, especially when higher doses or rapid administration are used.

Midazolam is contraindicated in patients with known hypersensitivity to benzodiazepines, those with severe respiratory insufficiency, acute narrow‑angle glaucoma, or in individuals who have taken large amounts of other CNS depressants. Caution is also advised for patients with myasthenia gravis or severe hepatic impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Midazolam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT